|Videos|April 19, 2021
Living with and Treatment Options for Spinal Muscular Atrophy
Pharmacy Times spoke with spinal muscular atrophy (SMA) patient Nick Sinagra about his treatment journey and his experiences with 2 different SMA treatments.
Advertisement
Pharmacy Times spoke with spinal muscular atrophy (SMA) patient Nick Sinagra about his treatment journey and his experiences with 2 different SMA treatments.
Sinagra discussed his experiences using SPINRAZA and Evrysdi, the challenges of living with SMA, what pharmacists need to understand about counseling patients with SMA, and what he hopes to see for the future of the rare disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
2
From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
3
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
4
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
5